Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability

NCT05878067 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05878067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05878067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Patient Experience Study With ABBV-444 for Symptom Relief and Tolerability
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
June 27, 2023
Completion date
October 6, 2023
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome